BioCatalystWatch
CLYMWorkspace / CLYM / OverviewCompany library
Price
Market cap
Next catalystDec 13, 2026Budoprutug IV — ITP · Phase 1 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

Budoprutug IV

CD19

PreINDP1P2P3FilingApproved
Upcoming / outlook

budoprutug

CD19

PreINDP1P2P3FilingApproved
Upcoming / outlook

budoprutugBudoprutug IV — ITP

CD19

PreINDP1P3FilingApproved
Upcoming / outlook

budoprutug

CD19

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

CLYM116

APRIL

PreINDP1P2FilingApproved
Upcoming / outlook

budoprutug

CD19

PreINDP1P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

budoprutugBudoprutug IV — ITP

CD19

PreINDP1P3FilingApproved
Upcoming / outlook

budoprutug

CD19

PreINDP2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Budoprutug IV

CD19

PreINDP1P2P3FilingApproved
Upcoming / outlook

budoprutug

CD19

PreINDP1P3FilingApproved
Upcoming / outlook

budoprutug

CD19

PreINDP1P2P3FilingApproved
Upcoming / outlook

CLYM116

APRIL

PreINDP1P2FilingApproved
Upcoming / outlook

Other pipelines

CLYM116

APRIL

PreINDP1P2P3FilingApproved

Partner / License out

CLYM116

APRIL

PreINDP1P2P3FilingApproved
Upcoming / outlook

CLYM116

APRIL

PreINDP1P2P3FilingApproved

History / paused

PreINDP1P2P3FilingApproved

GABAA receptor

PreINDP1P2P3FilingApproved

GABAA receptor

PreINDP1P2P3FilingApproved
budoprutug

CD19

PreINDP1P2P3FilingApproved
Budoprutug IV

CD19

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

CLYM PR & News

PR & News

CLYM SEC archive